Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2425 Locust St S, Canal Fulton, OH 44614 Phone: 330-854-1393 Fax: 330-266-7657 |
Greg Knight Optometrist, Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 2425 Locust St S, Canal Fulton, OH 44614 Phone: 330-854-1393 Fax: 330-266-7657 |
Mark W. Denman O.d. Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6569 Milhaven Ave Nw, Canal Fulton, OH 44614 Phone: 330-289-4441 |
Dr. Gregory J Knight, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2425 Locust St S, Canal Fulton, OH 44614 Phone: 330-854-1393 Fax: 330-266-7657 |
Anna Knight, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2425 Locust St S, Canal Fulton, OH 44614 Phone: 330-854-1393 Fax: 330-266-7657 |
News Archive
Tablet PC-based software application that allows psychologists and other treatment and educational staff to instantly file and retrieve patient information to and from a central database using wireless technology and the Internet.
Developing brain tumors can coax assistance from nearby cells known as microglia, according to a new study from scientists at Washington University School of Medicine in St. Louis.
The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients.
Deadly familial stomach and lobular breast cancers could be successfully treated at their earliest stages, or even prevented, by existing drugs that have been newly identified by cancer genetics researchers at New Zealand's University of Otago.
› Verified 9 days ago